Influence of Severe Gastrointestinal Complications in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma

References

• Al-Hamadani M, Habermann TM, Cerhan JR, Macon WR, Maurer MJ, Go RS. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the national cancer data base from 1998 to 2011. Am J Hematol. 2015;90(9):790–795. doi:10.1002/ajh.2408626096944
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end results database. Am J Hematol. 2014;89(3):310–314. doi:10.1002/ajh.2363824273125
   PubMed Web of Science ®Google Scholar
• Vaidya R, Habermann TM, Donohue JH, et al. Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol. 2013;24(9):2439–2443. doi:10.1093/annonc/mdt18823704194
   PubMed Web of Science ®Google Scholar
• Koch P, Del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma–results of the prospective German multicenter study GIT NHL 01/92. J clin oncol. 2001;19(18):3874–3883. doi:10.1200/JCO.2001.19.18.387411559725
   PubMed Web of Science ®Google Scholar
• Schmidt WP, Schmitz N, Sonnen R. Conservative management of gastric lymphoma: the treatment option of choice. Leuk Lymphoma. 2004;45(9):1847–1852. doi:10.1080/104281904200021947615223645
   PubMed Web of Science ®Google Scholar
• Gou HF, Zang J, Jiang M, Yang Y, Cao D, Chen XC. Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma. Med Oncol. 2012;29(1):227–234. doi:10.1007/s12032-010-9783-x21193968
   PubMed Web of Science ®Google Scholar
• Abbott S, Nikolousis E, Badger I. Intestinal lymphoma--a review of the management of emergency presentations to the general surgeon. Int J Colorectal Dis. 2015;30(2):151–157.25374417
   PubMed Web of Science ®Google Scholar
• Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80–89. doi:10.1002/bjs.1800492131913884035
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-64356926980727
   PubMed Web of Science ®Google Scholar
• Rohatiner A, d’Amore F, Coiffier B. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5(5):397–400. doi:10.1093/oxfordjournals.annonc.a0588698075046
   PubMed Web of Science ®Google Scholar
• Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J clin oncol. 2007;25(5):579–586. doi:10.1200/JCO.2006.09.240317242396
   PubMed Web of Science ®Google Scholar
• JW E, Eikelboom JW, Bosch J. Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2019;157(2):403–412.e405. doi:10.1053/j.gastro.2019.04.04131054846
   PubMed Web of Science ®Google Scholar
• Markogiannakis H, Messaris E, Dardamanis D, et al. Acute mechanical bowel obstruction: clinical presentation, etiology, management and outcome. World J Gastroenterol. 2007;13(3):432–437. doi:10.3748/wjg.v13.i3.43217230614
   PubMed Web of Science ®Google Scholar
• Kassam SA, Goldstone AH, Hoffbrand AV, Perez-Machado M, Mcnamara CJ. Rituximab does not increase the complication rate, particularly perforation, when added to chemotherapy for patients with primary b-cell lymphomas of the gastrointestinal tract. Blood. 2005;106(11):4742. doi:10.1182/blood.V106.11.4742.4742
   Web of Science ®Google Scholar
• Spectre G, Libster D, Grisariu S, et al. Bleeding, obstruction, and perforation in a series of patients with aggressive gastric lymphoma treated with primary chemotherapy. Ann Surg Oncol. 2006;13(11):1372–1378. doi:10.1245/s10434-006-9069-x17009162
   PubMed Web of Science ®Google Scholar
• Andreyev HJN, Davidson SE, Gillespie C, Allum WH, Swarbrick E. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012;61(2):179–192. doi:10.1136/gutjnl-2011-30056322057051
   PubMed Web of Science ®Google Scholar
• Schatz RA, Rockey DC. Gastrointestinal bleeding due to gastrointestinal tract malignancy: natural history, management, and outcomes. Dig Dis Sci. 2017;62(2):491–501. doi:10.1007/s10620-016-4368-y28032204
   PubMed Web of Science ®Google Scholar
• Koch P, Probst A, Berdel WE. Treatment results in localized primary gastric lymphoma: data of patients registered within the german multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23(28):7050–7059. doi:10.1200/JCO.2005.04.03116129843
   PubMed Web of Science ®Google Scholar
• Chin CK, Tsang E, Mediwake H, et al. Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement. Br J Haematol. 2019;184(5):826–828. doi:10.1111/bjh.1517329676487
   PubMed Web of Science ®Google Scholar
• Karstensen JG, Ebigbo A, Aabakken L, et al. Nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) cascade guideline. Endoscopy International Open. 2018;6(10):E1256–e1263. doi:10.1055/a-0677-208430302383
   PubMed Web of Science ®Google Scholar
• Holster IL, Kuipers EJ. Management of acute nonvariceal upper gastrointestinal bleeding: current policies and future perspectives. World J Gastroenterol. 2012;18(11):1202–1207. doi:10.3748/wjg.v18.i11.120222468083
   PubMed Web of Science ®Google Scholar
• Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38(3):316–321. doi:10.1136/gut.38.3.3168675081
   PubMed Web of Science ®Google Scholar
• Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356(9238):1318–1321. doi:10.1016/S0140-6736(00)02816-611073021
   PubMed Web of Science ®Google Scholar
• Laine L. Timing of endoscopy in patients hospitalized with upper gastrointestinal bleeding. N Engl J Med. 2020;382(14):1361–1363. doi:10.1056/NEJMe200212132242363
   PubMed Web of Science ®Google Scholar
• Oakland K, Chadwick G, East JE, et al. Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British society of gastroenterology. Gut. 2019;68(5):776–789. doi:10.1136/gutjnl-2018-31780730792244
   PubMed Web of Science ®Google Scholar
• Zheng L, Shin JH, Han K, et al. Transcatheter arterial embolization for gastrointestinal bleeding secondary to gastrointestinal lymphoma. Cardiovasc Intervent Radiol. 2016;39(11):1564–1572. doi:10.1007/s00270-016-1422-227435580
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47(10):a1–46. doi:10.1055/s-0034-139317226417980
   PubMed Web of Science ®Google Scholar
• Yasu T, Ohno N, Kawamata T, Kurokawa Y. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients. Int J Clin Pharmacol Ther. 2016;54(6):471–473. doi:10.5414/CP20258427087157
   PubMed Web of Science ®Google Scholar
• Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol. 2007;136(4):521–538. doi:10.1111/j.1365-2141.2006.06444.x17156403
   PubMed Web of Science ®Google Scholar
• Goy A, Ramchandren R, Ghosh N, et al. Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCL. Blood. 2019;134(13):1024–1036. doi:10.1182/blood.201889159831331917
   PubMed Web of Science ®Google Scholar